ELAVL1 and hepatocellular carcinoma: Binds to HuR, stabilizes PD-L1 expression, and enhances proliferation, migration, invasion and epithelial-mesenchymal transition of HCC cells. Inhibits cytotoxicity of CD8+ T cells, leading to immune escape